CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group. [electronic resource]
Producer: 20000111Description: 149-54 p. digitalISSN:- 1019-6439
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bleomycin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Doxorubicin -- administration & dosage
- Epirubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasm Staging
- Prednisone -- administration & dosage
- Survival Analysis
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.